Building a world where technology prevents organ failure

We believe the next giant Healthcare companies will develop algorithms used in care just as pharma companies develop molecules used as treatments.

Our Story

Predict4Health is founded on technical excellence and a deep commitment to patients.

The Paris Transplant Group developed the first universal predictive algorithm for transplantation in 2018 after 20 years of research. Our iBox technology is based on the Paris Transplant Group’s renowned scientific excellence and decades of experience caring for our own transplant patients.

We wanted to help patients worldwide by making our innovative technology available to everyone. With that goal, a team of scientific researchers and a team of entrepreneurs have joined forces to found Cibiltech in 2019. Predict4Health has acquired Cibiltech to continue and strengthen this project in 2023.

Together with a team of world-class scientists and business experts, we’re creating a world where science and technology work together in the service of human health.

Chartered accountant and legal auditor since 2010, Pierre has an MBA in market finance and a degree in chemical engineering. Pierre is a business management specialist and has accompanied many companies from their birth to their maturity.
Pierre Dillac
A restructuring professional for over 15 years, Stéphane helps companies grow and reinvent themselves. Particularly sensitive to the issue of organ failure, he joined Predict4Health with the ambition of supporting its development for the benefit of patients.
Stéphane Hoareau
Head of Engineering, has over 12 years experience in web development. He worked in multiple activity area, such as Education, E-commerce, Marketing, Luxury…
Yaniv Afriat
Chief Technical Officer
Dr Bellamine is specialized in digital health and health data science. He worked with major institutions and CRO in health data extraction, transformation and analysis.
Ali Bellamine
Chief Medical and Science Officer
After three years with the company, Victoria has developed a wide range of skills in market access, strategic development, finance and international collaboration.
Victoria Hemzacek
Chief Strategic Development Officer
Manon Thiberge
Chief Quality & Regulatory Officer
François Brunhes
Rozenn Cabioch
Head of Clinical Operations
Charline Mazou
Telemedicine nurse
Mathias Drouet-Tatin
Telemedicine Nurse
Arnaud Doubremelle
Web Developer
Valentin Bensamon
Web developer
Emma Chauvet
Product Manager
Yassine Khachlek
Web Developer
Rami Ismail
Web Developer
Eloge Katasi
Office Manager
Raphaël Assuline
Web Developer
Quentin Cherifi
Nahima Gueblaoui
Telemedicine nurse

Centered on the wellbeing of patients

We are dedicated to helping others when they are in difficulty and making everyone feel useful and valued.
Our goal is to prevent organ failure to preserve life and ensure the resilience of the healthcare system.
We have the ability to adapt quickly and efficiently to different innovation challenges in constantly changing environments.
We are determined to complete our projects, even if obstacles and barriers may occur.

Our story

Feb. 2019: Creation of Cibiltech

Cibiltech was founded to take a leap into the future of transplantation

Mar. 2019: Collaboration with CareDX

Collaboration with CareDX provides prognostic information on allograft survival on the American Market

Dec. 2019: Paris Innovation Grand Prix

The 2019 year ended with the prestigious Paris Innovation Grand Prix being awarded to us in E-Health category

Jun. 2020: EIT Health Laureate

We were announced among the 2020 winners of EIT Health's bridgehead global program

Jan. 2021: Predigraft platform launch

Launch in France for kidney transplanted patients

Apr. 2021: Health Tech Award

Finalist to the Nobel Project's Health Tech Award

May 2021: Class IIa Marking

Predigraft received CE marking as a class IIa under the MDR for kidney transplanted patients

Jul. 2021 : + 1000 patients

A new significant milestone for Cibiltech with more than 1000 patients using our app

Feb. 2022: 1st patient enrolled in our Clinical Trial

First patient enrolled in our International Clinical Trial for monitoring kidney Transplant patients using AI